AD
Publicaties op Oncologisch.com
Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO.
Health-related quality of life associated with fruquintinib in patiënten met metastatic colorectal cancer: Results fr...
Phase 3 Trial of Cabozantinib to Treat Gevorderd Neuroendocrine Tumors.
Fruquintinib versus placebo bij refractair gemetastaseerd CRC: FRESCO-2 fase III